Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic

• Main Authors: Li Wang, Man Jiang, Jialin Qu, Na Zhou, Xiaochun Zhang
• Format: Article
• Language: English
• Published: BMC 2020-09-01
• Series: Infectious Agents and Cancer
• Subjects: COVID-19; Lung cancer; Patient management
• Online Access: http://link.springer.com/article/10.1186/s13027-020-00322-7

Abstract The rapid growth of 2019 novel coronavirus (COVID-19) outbreak in Wuhan, China, at the early December 2019. COVID-19 spread all over the word just a few months. The outbreak of COVID-19 infection poses major threat to international health and economy. World Health Organization (WHO) announced that the new coronavirus was an international public health emergency on January 30, 2020. However, with the spread of COVID-19, the routine medical care of lung cancer patients was affected. Because lung cancer patients have low immunity after anti-tumor treatment, they should become the main targets for epidemic prevention. Lung cancer patients are increasingly concerned about the prevention of COVID-19. It is necessary to provide individualized medical treatment and management for lung cancer patients based on patients’ conditions and regional epidemic patterns.